This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The two biotechs, which have lost most of their share value following lucrative ...
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3...
Elsewhere, cell therapy developer Turnstone Biologics announced a second round o...
CagriSema, which underperformed expectations in its first Phase 3 test, will be ...